Inventurus Knowledge Solutions Limited
IKS · General/Diversified · NSE
₹1,675
Current Market Price
Fair Value (DCF)
₹866
Discount to FV
-48.3%
Updated 26m ago
YieldIQ Score
47/100
Piotroski F-Score
5/9
Economic Moat
Wide
Confidence
55%
ROE
25.8%
Debt/Equity
0.27
WACC
10.5%
Market Cap
₹28,076 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
30.9%
Return on capital employed
EV / EBITDA
29.9×
Enterprise multiple
Debt / EBITDA
0.9×
Leverage vs earnings
Interest Coverage
7.8×
EBIT covers interest
Current Ratio
1.50×
Short-term liquidity
Asset Turnover
1.05×
Revenue per ₹ of assets
Revenue CAGR (3Y)
17.3%
3-year revenue growth
Revenue CAGR (5Y)
30.9%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,675
Bear case
Margin of Safety —
Implied upside -266.5%
Base case
Margin of Safety -1421.4%
Implied upside -93.4%
Bull case
Margin of Safety -201.5%
Implied upside -66.8%
Ratio Trends
IKS · last 5 annual periods
ROE
25.8%
ROCE
30.9%
Operating Margin
—
Debt / Equity
0.27×
PE
—
EV / EBITDA
—
Historical Financials
IKS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 yfinance | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹764 Cr | ₹1031 Cr | ₹1817 Cr | ₹2664 Cr | ₹3194 Cr | +43.0% |
| EBITDA | ₹298 Cr | ₹389 Cr | ₹559 Cr | ₹809 Cr | ₹1099 Cr | +38.6% |
| EBIT | ₹275 Cr | ₹365 Cr | ₹501 Cr | ₹695 Cr | — | +26.1% |
| PAT | ₹233 Cr | ₹305 Cr | ₹370 Cr | ₹486 Cr | ₹722 Cr | +32.7% |
| EPS (diluted) | ₹13.58 | ₹17.79 | ₹21.59 | ₹28.62 | — | +20.5% |
| CFO | ₹233 Cr | ₹288 Cr | ₹210 Cr | ₹318 Cr | ₹674 Cr | +30.4% |
| CapEx | ₹-10.9 Cr | ₹-8.6 Cr | ₹-32.7 Cr | ₹-42.4 Cr | ₹-60.6 Cr | — |
| FCF | ₹222 Cr | ₹279 Cr | ₹177 Cr | ₹276 Cr | ₹613 Cr | +28.9% |
| Total Assets | ₹788 Cr | ₹988 Cr | ₹3028 Cr | ₹3052 Cr | ₹4268 Cr | +52.6% |
| Total Debt | ₹65.2 Cr | ₹52.3 Cr | ₹1311 Cr | ₹856 Cr | ₹753 Cr | +84.3% |
| Shareholders' Equity | ₹647 Cr | ₹829 Cr | ₹1158 Cr | ₹1790 Cr | ₹2800 Cr | +44.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
IKS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 LALPATHLAB Dr. Lal Path Labs Ltd. | -43.5%-30.3% upside | 50 | Above Fair Value | 22.4% | — |
 KIMS KIMS | — | — | Pending | 10.7% | — |
 PFIZER Pfizer Limited | -21.2%-17.5% upside | 43 | High Risk | 17.2% | — |
 WOCKPHARMA Wockhardt Limited | -528.9%-84.1% upside | 20 | Data Limited | 4.3% | — |
 ASTRAZEN AstraZeneca Pharma India Limited | -468.2%-82.4% upside | 40 | Data Limited | 21.5% | 103.5× |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for IKS in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Inventurus Knowledge Solutions Limited (IKS.NS) trades at 1675.00 vs a model fair value of 865.96, a gap of -48.3%. Piotroski F-score: 5/...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of IKS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for IKS →
Compare
Head-to-head with peers
Compare IKS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse IKSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.